KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
Nutrients. 2021 Mar 14;13(3):934. doi: 10.3390/nu13030934.
Allergic diseases including allergic rhinitis and asthma are increasing in the developing world, related to a westernizing lifestyle, while the prevalence is stable and decreasing in the industrialized world. This paper aims to answer the question if prevention and/or treatment of allergic rhinitis and asthma can be achieved by administrating pro-, pre- and/or synbiotics that might contribute to stabilizing the disturbed microbiome that influences the immune system through the gut-lung axis. We searched for relevant English articles in PubMed and Google Scholar. Articles interesting for the topic were selected using subject heading and key words. Interesting references in included articles were also considered. While there is substantial evidence from animal studies in well controlled conditions that selected probiotic strains may offer benefits in the prevention of wheezing and asthma, outcomes from clinical studies in infants (including as well pre- and postnatal administration) are disappointing. The latter may be related to the multiple confounding factors such as environment, strain selection and dosage, moment of administration and genetic background. There is little evidence to recommend administration of pro, pre- or synbiotics in the prevention of asthma and allergic rhinitis in children.
在发展中国家,与西方化生活方式有关的过敏性疾病(包括过敏性鼻炎和哮喘)正在增加,而在工业化国家,其发病率保持稳定并呈下降趋势。本文旨在回答以下问题:通过给予可能有助于稳定通过肠肺轴影响免疫系统的失调微生物组的益生菌、预生物和/或合生菌,是否可以预防和/或治疗过敏性鼻炎和哮喘。我们在 PubMed 和 Google Scholar 中搜索了相关的英文文章。使用主题词和关键词选择了与主题相关的文章。还考虑了包含文章中的有趣参考文献。虽然在精心控制的条件下,大量动物研究提供了证据表明,选择特定的益生菌菌株可能有益于预防喘息和哮喘,但婴儿(包括产前和产后)的临床研究结果令人失望。这可能与环境、菌株选择和剂量、给药时间和遗传背景等多种混杂因素有关。目前几乎没有证据表明在儿童中预防哮喘和过敏性鼻炎时应给予益生菌、预生物或合生菌。